Drugs / DW1029M
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT02212782 | Sep → Nov 2014 | — | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT02212756 | Aug 2014 → Jan 2015 | — | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT02212769 | Aug 2014 → Jan 2015 | — | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT02004327 | Dec 2013 | diabetic kidney disease | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01935167 | Oct 2013 → Aug 2014 | diabetic kidney disease | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DW1029M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02004327 ↗ |
| Route | Oral | “After Oral Administration” NCT02004327 ↗ |